Skip to main content

Table 4 odds ratio (95% CI) of general and abdominal obesity according to quintiles (Q) of fat quality indices

From: Dietary fat quantity and quality in relation to general and abdominal obesity in women: a cross-sectional study from Ghana

variable

GO (no/yes)

WC ≥ 80 cm (no/yes)

WHtR≥0.50(no/yes)

OR (95%CI)

P1

P2

OR (95%CI)

P1

P2

OR (95%CI)

P1

P2

PSR

 Q1(55)

Reference

        

 Q2 (56)

0.25(0.11–0.59)

  

0.15(0.06–0.37)

  

0.26(0.12–0.58)

  
 

0.26(0.09–0.72)

  

0.08(0.02–0.29)

  

0.24(0.08–0.69)

  

 Q3

0.26(0.11–0.60)

0.3

0.7

2.00(0.08–0.47)

0.3

0.6

0.44(0.21–0.95)

0.2

0.3

 

0.20(0.07–0.54)

  

0.07(0.02–0.24)

  

0.30(0.11–0.80)

  

 Q4

0.62(0.29–1.33)

  

0.72(0.34–1.53)

  

0.67(0.32–1.42)

  
 

0.75(0.29–1.89)

  

0.81(0.30–2.21)

  

0.74(0.28–1.92)

  

 Q5

0.55(0.25–1.18)

  

0.44(0.20–0.95)

  

0.37(0.17–0.82)

  
 

0.73(0.28–1.90)

  

0.49(0.18–1.40)

  

0.42(0.15–1.16)

  

∑ω-3/∑ω-6

 Q1 (55)

Reference

        

 Q2 (56)

2.42(1.07–5.48)

  

3.13(1.31–7.46)

  

2.68(1.17–6.16)

  
 

3.81(1.22–11.87)

  

3.11(0.91–10.70)

  

4.42(1.31–14.97)

  

 Q3 (55)

1.65(0.72–3.81)

0.01

0.005

2.13(0.87–5.16)

0.08

0.02

2.15(0.93–4.97)

0.9

0.8

 

3.03(0.82–11.14)

  

1.89(0.46–7.74)

  

5.33(1.34–21.12)

  

 Q4 (56)

2.50(1.10–5.67)

  

5.01(2.11–11.93)

  

5.37(2.32–12.41)

  
 

3.39(0.84–13.68)

  

3.14(0.70–14.15)

  

9.28(2.10–40.99)

  

 Q5 (55)

0.63(0.24–1.63)

  

1.00(0.37–2.63)

  

1.89(0.81–4.41)

  
 

0.79(0.22–2.81)

  

0.73(0.18–3.02)

  

3.59(0.99–12.99)

  

h/H

 Q1 (55)

Reference

        

 Q2 (56)

0.13(0.05–0.35)

  

0.13(0.05–0.35)

  

0.28(0.13–0.63)

  
 

0.13(0.04–0.40)

  

0.11(0.03–0.35)

  

0.27(0.10–0.75)

  

 Q3 (55)

0.50(0.23–1.09)

0.4

0.4

0.50(0.23–1.09)

0.6

0.3

0.51(0.24–1.10)

0.03

0.01

 

0.59(0.23–1.49)

  

0.46(0.17–1.24)

  

0.53(0.20–1.42)

  

 Q4 (56)

0.45(0.21–0.98)

  

0.45(0.21–0.98)

  

0.46(0.21–0.99)

  
 

0.55(0.22–1.40)

  

0.31(0.11–0.87)

  

0.39(0.14–1.06)

  

 Q5 (55)

0.43(0.19–0.94)

  

0.46(0.21–1.01)

  

0.29(0.13–0.65)

  
 

0.38(0.15–0.99)

  

0.39(0.14–1.06)

  

0.20(0.07–0.56)

  

AI

 Q1 (55)

Reference

        

 Q2 (56)

1.23(0.57–2.69)

  

1.24(0.56–2.74)

  

1.68(0.77–3.65)

  
 

1.89(0.68–5.14)

  

1.21(0.41–3.54)

  

2.55(0.88–7.46)

  

 Q3 (55)

0.70(0.31–1.61)

0.03

0.1

0.92(0.41–2.07)

0.008

0.01

1.61(0.73–3.52)

0.01

0.04

 

0.20(0.37–2.68)

  

1.12(0.40–3.15)

  

2.58(0.94–7.14)

  

 Q4 (56)

0.39(0.16–0.97)

  

0.37(0.15–0.96)

  

0.75(0.32–1.71)

  
 

0.40(0.13–1.19)

  

0.27(0.08–0.93)

  

0.99(0.33–3.00)

  

 Q5 (55)

1.98(0.91–4.29)

  

1.24(0.56–2.74)

  

2.89(1.32–6.31)

  
 

2.43(0.92–6.42)

  

2.30(1.07–8.38)

  

4.17(1.45–11.99)

  

TI

 Q1 (55)

Reference

        

 Q2 (56)

2.58(1.10–6.06)

  

2.78(1.19–6.51)

  

1.54(0.71–3.33)

  
 

2.76(1.07–7.16)

  

(2.580.96–6.93)

  

1.71(0.68–4.31)

  

 Q3 (55)

1.64(0.68–3.95)

0.003

0.01

1.50(0.61–3.64)

0.004

0.009

1.17(0.53–2.58)

0.02

0.03

 

1.69(0.62–4.65)

  

1.24(0.41–3.76)

  

1.03(0.38–2.79)

  

 Q4 (56)

1.09(0.43–2.73)

  

1.20(0.48–2.99)

  

0.82(0.36–1.84)

  
 

1.44(0.48–4.29)

  

1.10(0.35–3.48)

  

0.82(0.29–2.38)

  

 Q5 (55)

4.14(1.78–9.66)

  

4.14(1.78–9.66)

  

2.65(1.22–5.76)

  
 

4.93(1.74–13.95)

  

4.85(1.62–14.49)

  

3.01(1.08–8.39)

  

LI

 Q1 (55)

Reference

        

 Q2 (56)

0.97(0.43–2.18)

  

0.89(0.40–1.97)

  

1.54(0.71–3.33)

  
 

1.36(0.54–3.44)

  

1.71(0.64–4.52)

  

2.74(1.04–7.20)

  

 Q3 (55)

0.91(0.40–2.07)

0.006

0.01

0.71(0.31–1.60)

0.01

0.02

1.17(0.53–2.58)

0.004

0.007

 

1.30(0.51–3.32)

  

0.86(0.31–2.36)

  

1.90(0.72–5.07)

  

 Q4 (56)

0.48(0.19–1.18)

  

0.36(0.14–0.89)

  

0.62(0.26–1.43)

  
 

0.60(0.21–1.71)

  

0.28(0.09–0.92)

  

0.60(0.20–1.85)

  

 Q5 (55)

2.49(1.14–5.43)

  

2.11(0.98–4.55)

  

3.32(1.52–7.28)

  
 

3.26(1.27–8.39)

  

3.26(1.20–8.83)

  

5.81(2.06–16.41)

  

PSR

 Q1(55)

Reference

        

 Q2 (56)

1.35(0.61–3.01)

  

0.97(0.44–2.16)

  

1.32(0.61–2.85)

  
 

1.48(0.57–3.84)

  

1.22(0.44–3.36)

  

1.20(0.74–5.39)

  

 Q3

0.91(0.40–2.10)

0.08

0.06

1.09(0.49–2.39)

0.2

0.003

1.08(0.50–2.37)

0.1

0.009

 

0.97(0.36–2.64)

  

1.58(0.56–4.43)

  

1.55(0.56–4.33)

  

 Q4

0.73(0.32–1.73)

  

0.50(0.21–1.20)

  

1.05(0.48–2.30)

  
 

0.75(0.26–2.15)

  

0.75(0.24–2.38)

  

1.87(0.63–5.54)

  

 Q5

2.03(0.92–4.47)

  

1.59(0.73–3.46)

  

1.83(0.85–3.93)

  
 

2.54(0.91–7.04)

  

4.71(1.57–14.10)

  

4.44(1.52–13.00)

  
  1. P1: unadjusted; P2: adjusted for age (continuous); asset score (continuous); physical activity level (natural log transformed); dietary energy/kcal (continuous); woman education (categorical); husband education (categorical); occupation woman (categorical); occupation husband (categorical); marital status (categorical). In the multiple regression models, dummy variables were created for categorical covariates. P; Tests of linear trend across increasing PSR, ∑ω-3/∑ω-6, h/H, AI, TI, LI and TF were calculated for the models assessing chance of overweight/obesity as measured by body mass index, waist circumference and waist circumference to height ratio. To analyze these linear trends, the median values of PSR, ∑ω-3/∑ω-6, h/H, AI, TI, LI and TF were imputed for each quintile and the new variables were treated as continuous variables. All tests statistics are considered significant for P < 0.05, OR Odds ratio, CI Confidence Interval, GO General obesity (BMI ≥ 25), WC waist circumference, WHtR waist to height ratio, PSR polyunsaturated to saturated fatty acids ratio, ∑ω-3/∑ω-6; omega-3 to omega-6 fatty acids ratio, h/H hypo and hypercholesterolemic ratio, AI Atherogenicity index, TI Thrombogenic index, LI Dietary lipophilic index, TF Percentage of energy from total fat
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X